Summary
The presence of piroxicam in breast milk was determined by HPTLC during initial and long term dosing in 4 women treated for arthritis. Piroxicam appeared in breast milk at about 1–3% of the maternal plasma concentration. No accumulation of piroxicam occurred in milk relative to that in plasma up to 52 days of treatment. Neither piroxicam nor its conjugates were detectable in the urine of one breast-fed infant. The daily dose ingested by the infant was calculated to average 3.5% (maximum 6.3%) of the weight-related maternal dose of piroxicam. It is concluded that a breast-fed infant will be exposed to a very small amount of piroxicam.
References
Østensen M (1983) Piroxicam in human breast milk. Eur J Clin Pharmacol 25: 829–830
Riedel KD, Laufen H (1983) High performance thin-layer chromatographic assay for the routine determination of piroxicam in plasma, urine and tissue. J Chromatogr 276: 243–248
Brogden RN, Heel RC, Speight TM, Avery GS (1984) Piroxicam: A reappraisal of its pharmacology and therapeutic efficacy. Drugs 28: 292–323
Needs CJ, Brooks PM (1985) Antirheumatic medication during lactation. Br J Rheumatol 24: 291–297
Nation RL, Hackett LP, Dusci LI, Ilett KF (1984) Excretion of hydroxychloroquine in human milk. Br J Clin Pharmacol 17: 368–369
Østensen M, Brown ND, Chiang PK, Aarbakke J (1985) Hydroxychloroquine in human breast milk. Eur J Clin Pharmacol 28: 357
Gourley GR, Arend RA (1986) β-glucuronidase and hyperbilirubinaemia in breast-fed and formula-fed babies. Lancet 1: 644–646
Jamali F, Stevens DRS (1983) Naproxen excretion in milk and its uptake by the infant (letter). Drug Intell Clin Pharmacol 17: 910–911
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Østensen, M., Matheson, I. & Laufen, H. Piroxicam in breast milk after long-term treatment. Eur J Clin Pharmacol 35, 567–569 (1988). https://doi.org/10.1007/BF00558255
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558255